相关实验视频
Updated: Jan 13, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
标准化低剂量胰岛素输液协议在糖尿病狗的紧急稳定中的有效性
Franco González1, Felipe Díaz1, Ismael Pereira1
1Escuela de Medicina Veterinaria, Facultad de Medicina y Ciencias de la Salud, Universidad Mayor, Santiago 8580000, Chile.
Veterinary sciences
|October 28, 2025
概括
固定剂量连续速率输注0.05 IU/kg/h的胰岛素有效控制了糖尿病狗的血糖. 这种安全的协议简化了急性血糖管理,即使在早期酸性脂肪酸症的情况下也是如此.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 内分泌学 在内分泌学.
- 内部医学 内部医学
背景情况:
- 管理失补偿的糖尿病狗需要有效的胰岛素输液协议.
- 对于狗的可变和固定的胰岛素输注速率存在有限的比较数据.
研究的目的:
- 为了评估糖尿病狗的血糖反应,使用固定剂量的常规胰岛素连续速率输注 (CRI).
- 评估本协议对于急性血糖控制的安全性和有效性.
主要方法:
- 一项前性观察性研究,涉及21只糖尿病犬.
- 固定剂量的常规胰岛素0.05 IU/kg/h的CRI持续12小时.
- 每小时的毛细血管血糖监测和统计分析.
主要成果:
- 在前五小时内显著降低葡萄糖 (p < 0.0001).
- 随后葡萄糖水平稳定,没有进一步的显著变化.
- 没有观察到低血糖事件; 协议在性别和品种之间耐受良好.
结论:
- 固定剂量0.05 IU/kg/h的CRI是糖尿病犬急性血糖控制的安全有效治疗方法.
- 这种标准化协议简化了管理,而不会影响疗效.
- 该方案适用于紧急治疗,包括早期酸性的病例.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
673
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
673
Hypoglycemia and Glucagon
822
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
822

